Cochrane Database of Systematic Reviews 2004
DOI: 10.1002/14651858.cd003456.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Drug therapy for chronic idiopathic axonal polyneuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 102 publications
0
5
0
Order By: Relevance
“…Thirty percent of chronic idiopathic axonal polyneuropathy (CIAP) patients experience pain due to neuropathy 4 . No clinical studies have been reported concerning the treatment of neuropathic pain in CIAP patients 5 . Anticonvulsants and antidepressants are the first choice treatments for the reduction of neuropathic pain 6 .…”
Section: Introductionmentioning
confidence: 99%
“…Thirty percent of chronic idiopathic axonal polyneuropathy (CIAP) patients experience pain due to neuropathy 4 . No clinical studies have been reported concerning the treatment of neuropathic pain in CIAP patients 5 . Anticonvulsants and antidepressants are the first choice treatments for the reduction of neuropathic pain 6 .…”
Section: Introductionmentioning
confidence: 99%
“…Here, we studied two types of chronic acquired polyneuropathies whose diagnosis can be challenging, chronic inflammatory demyelinating polyneuropathy (CIDP) and chronic idiopathic axonal polyneuropathy (CIAP). The distinction is important since specific treatment options are available for CIDP [3], whereas there is none of proven efficacy for CIAP [4].…”
Section: Introductionmentioning
confidence: 99%
“…NRS score reductions percent (ΔNRS%) were quantified by (3,4). Many patients with CIAP suffer from neuropathic pain (5), which is managed using several oral medications (e.g., pregabalin, gabapentin, amitriptyline, and palmitoylethanolamide) and modalities (6,7). However, despite these treatments, pain persists in some patients.…”
Section: Outcome Measuresmentioning
confidence: 99%